We’re excited to bring you the September 2025 edition of the KidWell newsletter. This issue includes new resources, updates, and important reminders to support your practice and our shared mission. This month’s highlights include:
Delaware’s Birth to Three Early Intervention Program supports families with infants and toddlers who have or are at risk of developmental delays or disabilities. The program’s mission is to empower parents and caregivers by providing comprehensive resources and services tailored to each child’s unique needs.
Respiratory syncytial virus (RSV) is a widespread respiratory virus that poses serious health risks for infants and young children. To combat this, the Centers for Disease Control and Prevention (CDC) now recommends RSFP immunization to help prevent severe RSV disease. This can be achieved through maternal vaccination or the administration of the RSV monoclonal antibody (nirsevimab) to infants.
In September 2024, the U.S. Food and Drug Administration (FDA) granted approval for FluMist, the nasal spray influenza vaccine, to be administered by individuals themselves or by caregivers. This new option provides a safe and effective alternative of receiving the seasonal influenza vaccine, offering increased convenience and flexibility for families.
